false
0001864531
0001864531
2024-02-13
2024-02-13
0001864531
dhacu:UnitsEachConsistingOfOneShareOfCommonStockAndOneRedeemableWarrantMember
2024-02-13
2024-02-13
0001864531
us-gaap:CommonStockMember
2024-02-13
2024-02-13
0001864531
dhacu:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOfDollar11.50Member
2024-02-13
2024-02-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 13, 2024
Digital Health Acquisition Corp.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-41015 |
|
86-2970927 |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
980 N Federal Hwy #304
Boca
Raton, FL 33432
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including
area code: (561) 672-7068
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
Title of
each class |
|
Trading
Symbol(s) |
|
Name of
each
exchange on which
registered |
Units, each consisting of one share of Common Stock and one Redeemable Warrant |
|
DHACU |
|
The Nasdaq Stock Market LLC |
Common Stock, par value $0.0001 per share |
|
DHAC |
|
The Nasdaq Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 |
|
DHACW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement
Third Amended and Restated Business Combination Agreement
As previously disclosed in
its Current Reports on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on November 22, 2023, on November
21, 2023, Digital Health Acquisition Corp. (“DHAC” or the “Company”), DHAC Merger Sub I, Inc., a Delaware corporation
and a wholly owned subsidiary of DHAC (“Merger Sub I”), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary
of DHAC (“Merger Sub II” and together with Merger Sub I, the “Merger Subs”), VSee Lab, Inc., a Delaware corporation
(“VSee”), and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc” and together with DHAC, Merger
Sub I, Merger Sub II, VSee and iDoc, the “Parties”), entered into a Third Amended and Restated Business Combination Agreement
(the “Third A&R Business Combination Agreement”).
On February 13, 2023, the
parties to the Business Combination Agreement entered into the First Amendment to Third Amended and Restated Business Combination Agreement
(the “First Amendment”), pursuant to which the Business Combination Agreement was amended to, among other things, provide
that certain indebtedness of VSee and iDoc would be assumed by DHAC in connection with the business combination and converted into DHAC
common stock following the closing.
The foregoing description
of the First Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions of the First Amendment
filed as Exhibit 2.1 hereto and incorporated by reference herein.
Loan Conversion
On November 21, 2023, the
Company, VSee, and/or iDoc, as applicable, entered into securities purchase agreements (the “Conversion SPAs”) with various
lenders of each of the Company, VSee and iDoc.
On February 13, 2024,
the Company, VSee and/ or iDoc, as applicable, amended and restated certain of the Conversion SPAs (the “Amended and Restated
Conversion SPAs”) pursuant to which (1) a $600,000 balance of certain indebtedness of VSee will be assumed by the Company and
converted into the Company’s common stock after the closing of the business combination; (2) a $600,000 balance certain
indebtedness of iDoc will be assumed by the Company and will then be converted into the Company’s common stock subject to
executing of certain registration rights agreement and filing of a registration statement thereunder after the closing of the
business combination; and (3) certain indebtedness owned by iDoc will be assumed by the Company and will then be converted into the
Company’s common stock subject to executing of certain registration rights agreement and filing of a registration statement
thereunder after the closing of the business combination.
The foregoing description
of the Amended and Restated Conversion SPAs do not purport to be complete and are qualified in their entirety by the terms and conditions
of the forms of Amended and Restated Conversion SPAs filed as Exhibit 10.1 and Exhibit 10.2 hereto and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit |
Description |
2.1 |
First Amendment to the Third Amended and Restated Business Combination Agreement, dated as of February 13, 2024, by and among Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. |
|
|
10.1 |
Form of Amended and Restated Conversion Securities Purchase Agreement with the Bridge Investor for Shares of Common Stock in Digital Health Acquisition Corp. |
|
|
10.2 |
Form of Amended and Restated Conversion Securities Purchase Agreement with Tidewater for Shares of Common Stock in Digital Health Acquisition Corp. |
|
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 13, 2024 |
DIGITAL HEALTH ACQUISITION CORP. |
|
|
|
By: |
/s/ Scott Wolf |
|
Name: |
Scott Wolf |
|
Title: |
Chief Executive Officer and Chairman |
Exhibit 2.1
DIGITAL
HEALTH ACQUISITION CORP.
FIRST
AMENDMENT AND WAIVER
This First Amendment and Waiver
(this “Amendment”) is made effective as of February 13, 2024 (the “Effective Date”), by and among
Digital Health Acquisition Corp., a Delaware corporation (the “Company”), DHAC Merger Sub I, Inc., DHAC Merger Sub
II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (each, a “Party” and collectively, the “Parties”).
Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Third Amended and Restated Business
Combination Agreement dated November 21, 2023 among the Company and the Parties (the “Original BCA” and as amended
by this Amendment, the “Agreement”).
RECITALS
A. WHEREAS,
on November 21, 2023, the Company and the Parties entered into the Original BCA; and
B. WHEREAS,
the Parties desire to amend and waive the Original BCA to reflect the terms of the transactions contemplated by the Registration Statement
/ Proxy Statement on Form S-4.
NOW, THEREFORE, the undersigned
Parties hereby agree as follows:
1.
Effect of this Agreement. The Original BCA will remain in full force and effect except as expressly modified by this Agreement.
2.
Omnibus Amendments and Waivers. The Company and the applicable Parties hereby agree as follows:
2.1 The following definitions in Section 1.1 of the Original BCA are hereby deleted in their entirety:
(a)
iDoc Class B Common Stock
(b)
iDoc Class B Consideration
(c)
iDoc Class B Outstanding Shares
(d)
iDoc Per Share Class B Consideration
(e)
VSee Class B Common Stock
(f)
VSee Class B Consideration
(g)
VSee Class B Outstanding Shares
(h)
VSee Per Share Class B Consideration
2.2 The definition of “iDoc Closing Consideration” set forth in Section 1.1 of the Original BCA and the term as used throughout
the Original BCA shall be amended and restated as follows:
“iDoc Closing Consideration” means the
iDoc Class A Consideration.
2.3 The
definition of “iDoc Common Stock” set forth in Section 1.1 of the Original BCA and the term as used throughout the Original
BCA shall be amended and restated as follows:
“iDoc Common Stock” means the
iDoc Class A Common Stock.
2.4 The
definition of “iDoc Per Share Consideration” set forth in Section 1.1 of the Original BCA and the term as used throughout
the Original BCA shall be amended and restated as follows:
“iDoc Per Share Consideration”
means the iDoc Per Share Class A Consideration.
2.5 The
definition of “Target Loan Conversions” set forth in Section 1.1 of the Original BCA and the term as used throughout the
Original BCA shall be amended and restated as follows:
“Target Loan Conversions”
means the transactions contemplated by the Securities Purchase Agreements entered into on November 21, 2023, and as amended and restated
on February 13, 2024, with various holders of indebtedness of iDoc and VSee pursuant to which DHAC will assume such indebtedness in connection
with the Business Combination and such holders agreed to subscribe for and purchase, and DHAC agreed to issue and sell to such holders,
immediately following the Closing Date, shares of DHAC Common Stock, in consideration for the conversion of such indebtedness.”
2.6 The
definition of “VSee Closing Consideration” set forth in Section 1.1 of the Original BCA and the term as used throughout the
Original BCA shall be amended and restated as follows:
“VSee Closing Consideration”
means the VSee Class A Consideration.
2.7 The
definition of “VSee Common Stock” set forth in Section 1.1 of the Original BCA and the term as used throughout the Original
BCA shall be amended and restated as follows:
“VSee Common Stock”
means the VSee Class A Common Stock.
2.8 The
definition of “VSee Per Share Consideration” set forth in Section 1.1 of the Original BCA and the term as used throughout
the Original BCA shall be amended and restated as follows:
“VSee Per Share Consideration”
means the VSee Per Share Class A Consideration.
2.9
Section 2.1(b)(ii) of the Original BCA shall be amended and restated as follows:
“At the Effective
Time, by virtue of the applicable Merger and without any action on the part of any Party or any other Person, each share of VSee Class
A Common Stock (other than VSee Dissenting Shares and such shares of VSee Class A Common Stock cancelled and extinguished pursuant to
Section 2.1(d)(iii)) issued and outstanding as of immediately prior to the Effective Time shall be automatically canceled and extinguished
and converted into the right to receive the VSee Per Share Class A Consideration, subject to adjustment for indemnification claims in
accordance with Article 8.”
2.10 Section
2.1(c) of the Original BCA shall be amended and restated as follows:
“Effect on iDoc
Securities. At the Effective Time, by virtue of the applicable Merger and without any action on the part of any Party or any other
Person, each share of iDoc Class A Common Stock (other than iDoc Dissenting Shares and such shares of iDoc Class A Common Stock cancelled
and extinguished pursuant to Section 2.1(d)(iii)) issued and outstanding as of immediately prior to the Effective Time shall be
automatically canceled and extinguished and converted into the right to receive the iDoc Per Share Class A Consideration subject to adjustment
for indemnification claims in accordance with Article 8.”
2.11 Section
5.1(c) of the Original BCA shall be added as follows:
“Neither iDoc nor
VSee will issue any shares of Class B Common Stock prior to the Closing.”
3.
Waivers and Agreements. The Company and the applicable Parties hereby agree as follows:
3.1
The Parties hereby consent to the execution of the (i) Amended and Restated Securities Purchase Agreement dated February 13, 2024,
by and among iDoc Virtual Telehealth Solutions, Inc., Digital Health Acquisition Corp, and Dominion Capital LLC; (ii) Amended and Restated
Securities Purchase Agreement dated February 13, 2024, by and among VSee Lab, Inc., Digital Health Acquisition Corp, and Dominion Capital
LLC; and (iii) Amended and Restated Securities Purchase Agreement dated February 13, 2024, by and among iDoc Virtual Telehealth Solutions,
Inc., Digital Health Acquisition Corp., and Tidewater Ventures, LLC.
4.
Miscellaneous. Article 9 of the Original BCA is hereby incorporated by reference and shall apply to this Amendment.
[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, each of
the Parties has caused this First Amendment to the Third Amended and Restated Business Combination Agreement to be duly executed on its
behalf as of the day and year first above written.
|
DIGITAL HEALTH ACQUISITION CORP. |
|
|
|
By: |
/s/ Scott Wolf |
|
Name: Scott Wolf |
|
Title: Chief Executive Officer |
|
|
|
DHAC MERGER SUB I, INC. |
|
|
|
By: |
/s/ Scott Wolf |
|
Name: Scott Wolf |
|
Title: President |
|
|
|
DHAC MERGER SUB II, INC. |
|
|
|
By: |
/s/ Scott Wolf |
|
Name: Scott Wolf |
|
Title: President |
Signature Page to First
Amendment
IN WITNESS WHEREOF, each of
the Parties has caused this First Amendment to the Third Amended and Restated Business Combination Agreement to be duly executed on its
behalf as of the day and year first above written.
|
VSEE LAB, INC. |
|
|
|
By: |
/s/ Milton Chen |
|
Name: Milton Chen |
|
Title: Executive Vice Chairman |
|
|
|
IDOC VIRTUAL TELEHEALTH SOLUTIONS, INC. |
|
|
|
By: |
/s/ Dr. Imoigele Aisiku |
|
Name: Dr. Imoigele Aisiku |
|
Title: Executive Chairman |
Signature Page to First
Amendment
Exhibit 10.1
amended and restated
SECURITIES PURCHASE AGREEMENT
This AMENDED AND RESTATED
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 13, 2024, is by and among [iDoc Virtual Telehealth
Solutions, Inc., a Texas corporation (“iDoc”),/VSee Lab, Inc., a Delaware corporation (“VSee”)],
Digital Health Acquisition Corp, a Delaware corporation (the “Company”), and [INVESTOR], a Connecticut limited liability
company (“[INVESTOR]”, together with [iDoc/VSee] and the Company the “Parties”). For purposes of
this Agreement, references to the “Company” shall also include, after the closing of the Business Combination (as defined
below), the resulting publicly listed company pursuant to the transactions contemplated by the Third Amended and Restated Business Combination
Agreement, dated November 21, 2023 (as it may be further amended or supplemented from time to time, the “Business Combination
Agreement”), by and between the Company, DHAC Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the
Company (“Merger Sub I”), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary of the Company(“Merger
Sub II”), [VSee Lab, Inc. a Delaware corporation (“VSee”)/ iDoc Virtual Telehealth Solutions, Inc., a Texas corporation
(‘iDoc”)], and [iDoc/VSee] pursuant to which, upon the terms and subject to the conditions contained therein, Merger Sub I
will merge with and into VSee, with VSee surviving the merger as a wholly owned subsidiary of the Company, and Merger Sub II will merge
with and into iDoc, with iDoc surviving the merger as a wholly owned subsidiary of the Company (collectively, the “Mergers”).
In connection with the Business Combination, at the effective time of the Mergers the Company will change its corporate name to VSee Health,
Inc. The Mergers and the other transactions described in the Business Combination Agreement are collectively referred to herein as the
“Business Combination”.
RECITALS
A. The
Parties previously entered into entered into that certain Securities Purchase Agreement dated November 21, 2023 (the “Existing
Agreement”) and now desire to amend and restate the Existing Agreement in its entirety.
B. The Parties are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by
Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b) of Regulation D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act.
C. [iDoc/VSee]
previously issued and delivered to [INVESTOR] a promissory note in the principal amount (excluding the original issue discount) of $600,000.00
(the “Note”), such amount (the “Loan Amount”) being currently due and payable.
D.
In connection with the Business Combination, the Note will be assumed by the Company.
E.
Following the closing of the Business Combination, [INVESTOR] wishes to convert the entire Loan Amount into shares of the Company’s
common stock (the “Company Common Stock”) at $2.00 per share (the “Shares”) upon the Company’s
registration of the Shares issuable upon conversion of the Loan Amount, and the Company wishes to sell [INVESTOR] such Shares at such
time, upon the terms and conditions stated in this Agreement.
F. Following
the closing of the Business Combination, the Company will register the Shares issuable upon conversion of the Loan Amount pursuant to
a Registration Rights Agreement (defined below).
NOW THEREFORE, THE PARTIES
AGREE AS FOLLOWS:
1.0 Definitions.
In
addition to the terms defined elsewhere in this Agreement, the following terms have the meanings set forth in this Section 1.0:
“Affiliate”
means each Person that controls, is controlled by or is under common control with such Person or any Affiliate of such Person. For purpose
of this definition, “control” and related words are used as such terms are used in and construed under Rule 405 under
the Securities Act. Notwithstanding the foregoing, the Holders and their Subsidiaries, on the one hand, and the Company Parties and their
Subsidiaries, on the other hand, shall not be considered “Affiliates” of each other.
“Board
of Directors” means the board of directors of the applicable Company.
“Business Combination”
means the consummation of the proposed business combination in accordance with the terms and conditions set forth in the Business Combination
Agreement.
“Capital
Stock” means any share, participation or other equivalent (however designated) of the capital stock of a corporation,
any equivalent ownership interest in any other Person, including partnership interests and membership interests, and any warrant, right
or option to purchase or other arrangement (including through a conversion or exchange of any other property) to acquire or subscribe
for any item otherwise satisfying the definition of “Capital Stock,” whether or not presently convertible, exchangeable or
exercisable.
“Closing”
means the closing of the issuance the Shares.
“Commission”
means the United States Securities and Exchange Commission.
“Company
Party” means [iDoc/VSee], the Company and their respective Subsidiaries.
“Consents”
means any approval, consent, authorization, notice to, or any other action by, any Person other than any Governmental Authority.
“Contractual
Obligation” means, with respect to any Person, any provision of any security or similar instrument issued by such Person or
of any agreement, undertaking, contract, lease, indenture, mortgage, deed of trust or other instrument (other than a Transaction Document)
to which such Person is a party or by which it or any of its property is bound or to which any of its property is subject.
“Disclosure
Schedule” means a schedule disclosing detailed information about the Company Parties and the Collateral in form and substance
satisfactory to the Holders on the Closing, together with any update on the Collateral or any other information in such certificate required
to be given and given in accordance with any Transaction Document.
“Exchange
Act” means the Securities Exchange Act of 1934.
“GAAP”
means United States generally accepted accounting principles as in effect from time to time, applied consistently throughout the
periods referenced and consistently with (a) the principles and standards set forth in the opinions and pronouncements of the Financial
Accounting Standards Board or any successor entity, (b) to the extent consistent with such principles, generally accepted industry
practices and (c) to the extent consistent with such principles and practices, the past practices of the Company as reflected in its financial
statements disclosed in SEC Reports.
“Governmental
Authority” means any nation, sovereign or government, any state, province, territory or other political subdivision thereof,
any municipality, any agency, authority or instrumentality thereof and any entity or authority exercising executive, legislative, taxing,
judicial, regulatory or administrative functions of or pertaining to government, and any corporation or other entity owned or controlled,
through stock or capital ownership or otherwise, by any of the foregoing, including any central bank stock exchange regulatory body arbitrator,
public sector entity, supra-national entity (including the European Union and the European Central Bank) and any self-regulatory organization
(including the National Association of Insurance Commissioners).
“Indebtedness”
means, with respect to any Person, without duplication, the following: (a) all indebtedness of such Person for borrowed money, (b) all
obligations of such Person for the deferred purchase price of property or services other than accounts payable and accrued liabilities
incurred in respect of property or services purchased in the ordinary course of business (provided, that such accounts payable
and accrued liabilities are not overdue by more than 180 days), (c) all obligations of such Person evidenced by notes, bonds, debentures
or similar borrowing or securities instruments, (d) all obligations of such Person created or arising under any conditional sale or other
title retention agreement with respect to property acquired by such Person, (e) all obligations of such Person as lessee under Capital
Leases, (f) all reimbursements and all other obligations of such Person with respect to (i) letters of credit, bank guarantees or bankers’
acceptances or (ii) surety, customs, reclamation, performance or other similar bonds, (g) all obligations of such Person secured by Liens
on the assets of such Person, (h) all Guaranty Obligations of such Person, (i) all obligations of such Person to purchase, redeem, retire,
defease or otherwise make any payment in respect of any Capital Stock, Stock Equivalent (valued, in the case of redeemable preferred stock,
at the greater of its voluntary liquidation preference and its involuntary liquidation preference plus accrued and unpaid dividends) or
any warrants, rights or options to acquire such Capital Stock, (j) after taking into account the effect of any legally-enforceable
netting Contractual Obligation of such Person, all payments that would be required to be made in respect of any Derivative in the event
of a termination (including an early termination) on the date of determination and (k) all obligations of another Person of the type described
in clauses (a) through (j) secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to
be secured by) a Lien on the assets of such Person (whether or not such Person is otherwise liable for such obligations of such other
Person).
“Intellectual
Property Rights” means, collectively, all copyrights, patents, trademarks, service marks and trade names all applications for
any of the foregoing, together with: (i) all inventions, processes, production methods, proprietary information, know-how and trade
secrets; (ii) all licenses or user or other agreements granted with respect to any of the foregoing, in each case whether now or
hereafter owned or used; (iii) all customer lists, identification of suppliers, data, plans, blueprints, specifications, designs, drawings,
recorded knowledge, surveys, engineering reports, test reports, manuals, materials standards, processing standards, performance standards,
catalogs, computer and automatic machinery software and programs; (iv) all field repair data, sales data and other information relating
to sales or service of products now or hereafter manufactured; (v) all accounting information and all media in which or on which any information
or knowledge or data or records may be recorded or stored and all computer programs used for the compilation or printout of such information,
knowledge, records or data; (vi) all applications for any of the foregoing and (vii) all causes of action, claims and warranties, in each
case, now or hereafter owned or acquired in respect of any item listed above.
“Liabilities”
means all amounts, indebtedness, obligations, liabilities, covenants and duties of every type and description owing by any Company Party
from time to time to any Holder or any other Holder Party, whether direct or indirect, joint or several, absolute or contingent, due or
to become due, liquidated or unliquidated, secured or unsecured, now existing or hereafter arising and however created, acquired (regardless
of whether acquired by assignment), whether or not evidenced by any note or other instrument or for the payment of money and whether arising
under Contractual Obligations, Regulations or otherwise, including, without duplication, (i) the principal amount due of the Notes, (ii)
all other amounts, fees, interest (including any prepayment premium), commissions, charges, costs, expenses, attorneys’ fees and
disbursements, indemnities, reimbursement of amounts paid and other sums chargeable to the Company under the Notes, this Agreement or
any other Transaction Document (including attorneys’ fees) or otherwise arising under any Transaction Document and (iii) all interest
on any item otherwise qualifying as a “Liability” hereunder, whether or not accruing after the filing of any petition in bankruptcy,
or the commencement of any insolvency, reorganization or similar proceeding, whether or not a claim for post-filing or post-petition interest
is allowed in such proceeding.
“License Agreement”
has the meaning ascribed to such term in Section 3.1(m).
“Lien”
means any lien (statutory or other) mortgage, pledge, hypothecation, assignment, security interest, encumbrance, charge, claim, right
of first refusal, preemptive right, restriction on transfer or similar restriction or other security arrangement of any kind or nature
whatsoever, including any conditional sale or other title retention agreement and any capital or financing lease having substantially
the same economic effect as any of the foregoing.
“Losses”
means all liabilities, rights, demands, covenants, duties, obligations (including indebtedness, receivables and other contractual obligations),
claims, damages, Proceedings and causes of actions, settlements, judgments, damages, losses (including reductions in yield), debts, responsibilities,
fines, penalties, sanctions, commissions and interest, disbursements, Taxes, interest, charges, costs, fees and expenses (including fees,
charges, and disbursements of financial, legal and other advisors, consultants and professionals and, if applicable, any value-added and
other taxes and charges thereon), in each case of any kind or nature, whether joint or several, whether now existing or hereafter arising
and however acquired and whether or not known, asserted, direct, contingent, liquidated, due, consequential, actual, punitive or treble.
“Material
Adverse Effect” means material adverse effect on, or change in, (a) the legality, validity or enforceability of
any portion of any Transaction Document, (b) the operations, assets, business, prospects or condition (financial or otherwise) of
any Company Party, (c) the ability of any Company Party to perform on a timely basis its obligations under any Transaction Document
for any reason whatsoever, whether foreseen or unforeseen, including due to pandemic, acts of a Governmental Authority, interruption of
transportation systems, strikes, terrorist activities, interruptions of supply chains or acts of God, or (d) the Collateral or the perfection
or priority of any Liens granted to any Holder Party under any Transaction Document.
“Permit”
means, with respect to any Person, any permit, filing, notice, license, approval, variance, exception, permission, concession, grant,
franchise, confirmation, endorsement, waiver, certification, registration, qualification, clearance or other Contractual Obligation or
arrangement with, or authorization by, to or under the authority of, any Governmental Authority or pursuant to any Regulation, or any
other action by any Governmental Authority in each case whether or not having the force of law and affecting or applicable to or binding
upon such Person, its Contractual Obligations or arrangements or other liabilities or any of its property or to which such Person, its
Contractual Obligations or any of its property is or is purported to be subject.
“Person”
means an individual, partnership, corporation, incorporated or unincorporated association, limited liability company, limited liability
partnership, joint stock company, land trust, business trust or unincorporated organization, or a government or agency, department or
other subdivision thereof or other entity of any kind.
“Proceeding”
against a Person means an action, suit, litigation, arbitration, investigation, complaint, dispute, contest, hearing, inquiry, inquest,
audit, examination or other proceeding threatened or pending against, affecting or purporting to affect such Person or its property, whether
civil, criminal, administrative, investigative or appellate, in law or equity before any arbitrator or Governmental Authority.
“Regulation”
means, all international, federal, state, provincial and local laws (whether civil or common law or rule of equity and whether U.S. or
non- U.S.), treaties, constitutions, statutes, codes, tariffs, rules, guidelines, regulations, writs, injunctions, orders, judgments,
decrees, ordinances and administrative or judicial precedents or authorities, including, in each case whether or not having the force
of law, the interpretation or administration thereof by any Governmental Authority, all policies, recommendations or guidance of any Governmental
Authority and all administrative orders, directed duties, directives, requirements, requests.
“Restricted
Payment” means, for any Person, (a) any dividend, stock split or other distribution, direct or indirect (including by way of
spin off, reclassification, corporate rearrangement, scheme of arrangement or similar transaction), on account of, or otherwise to the
holder or holders of, any shares of any class of Capital Stock of such Person now or hereafter outstanding, (b) any redemption, retirement,
sinking fund or similar payment, purchase or other acquisition for value, direct or indirect, of any shares of any class of Capital Stock
of such Person by such Person or any Affiliate thereof now or hereafter outstanding, and (c) any payment made to retire, or to obtain
the surrender of, any Stock Equivalents now or hereafter outstanding; provided, that, for the avoidance of doubt, (i) a cashless
exercise of an employee stock option in which options are cancelled to the extent needed such that the “in-the-money” value
of the options (i.e. the excess of market price over exercise price) that are cancelled is utilized to pay the exercise price, and applicable
taxes, shall not be a “Restricted Payment” and (ii) a distribution of rights (including rights to receive assets) or
options shall constitute a “Restricted Payment”.
“SEC
Reports” means all reports, schedules, forms, statements and other documents filed or required to be filed by the Company under
the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one (1) year preceding the date
hereof (or such shorter period as the Company was required by Regulation to file such material) including the exhibits thereto and documents
incorporated by reference therein.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Stock
Equivalents” means all securities and/or Indebtedness convertible into or exchangeable for Capital Stock or any other Stock
Equivalent and all warrants, options, scrip rights, calls or commitments of any character
whatsoever, and all other rights or options or other arrangements (including through a conversion or exchange of any other property) to
purchase, subscribe for or acquire, any Capital Stock or any other Stock Equivalent, whether or not presently convertible, exchangeable
or exercisable.
“Subsidiary”
means (a) any subsidiary of the respective Company as set forth in, or otherwise required to be set forth in, the SEC Reports, both on
or after the date hereof, and (b) any Person (other than natural persons) the management of which is, directly or indirectly, controlled
by, or of which an aggregate of 50% or more of the outstanding Voting Stock is, at the time, owned or controlled, directly or indirectly,
by such Person or one or more Subsidiaries of such Person.
“Trading
Day” means a day on which the principal Trading Market for the Common Stock is
open for trading.
“Transaction
Documents” means this Agreement, the Disclosure Schedules, and any other documents or agreements executed in connection with
the transactions contemplated hereunder.
2.0 Basic
Terms of Purchase and Sale.
2.1
Purchase and Sale of Shares.
(a)
Subject to the terms and conditions of this Agreement, [INVESTOR] agrees to purchase from the Company, and the Company agrees to
sell and issue to [INVESTOR], 300,000 Shares at a price of $2.00 per Share (to facilitate the issuance of shares in accordance with the
provisions of this Agreement, the number of Shares allocated to [INVESTOR] is rounded up to the nearest whole number), effective upon
the Company’s filing of a registration statement with respect to the Shares pursuant to the Registration Rights Agreement. Each
of the Parties acknowledges that the Loan Amount shall be the only consideration to be payable in full satisfaction of the purchase price
for the Shares.
(b)
At the closing of the purchase and sale of the Shares, the Company shall deliver to [INVESTOR], at [INVESTOR]’s option, a
certificate or book entry statement representing 300,000 Shares, and [INVESTOR] shall deliver to the Company evidence of the cancellation
of the Loan Amount.
3.0 Representations
and Warranties of [iDoc/VSee] and the Company
3.1 Representations and Warranties of [iDoc/VSee] and the Company. Except as set forth in the SEC Reports or on the Disclosure
Schedules, each of [iDoc/VSee] and the Company, jointly and severally, hereby represents and warrants to [INVESTOR] as of the Closing
as follows:
(a) Incorporation. Each of [iDoc/VSee] and the Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of its incorporation and each has all requisite corporate power and authority to carry on its business as
now conducted and as proposed to be conducted.
(b) Authorization.
All corporate action on the part of each of [iDoc/VSee] and the Company, its officers, directors and shareholders necessary for the authorization,
execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and therein, and for
the authorization, issuance and delivery of the Shares and the Company Common Stock, has been or shall be taken prior to the Closing,
and this Agreement, when executed and delivered, shall constitute the legal, valid and binding obligation of each of [iDoc/VSee] and
the Company, enforceable against each of them in accordance with their respective terms, except as limited by applicable bankruptcy,
insolvency, reorganization, moratorium, or other laws of general application relating to or affecting the enforcement of creditors’
rights. [iDoc/VSee] has all requisite legal and corporate power to enter into this Agreement, to sell the Shares hereunder, and to carry
out and perform its obligations hereunder.
(c) Non-Contravention.
The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby will not result in a violation
or breach by [iDoc/VSee] or the Company, or constitute a default by [iDoc/VSee] or the Company under, their respective organizational
documents, any applicable law, rule or regulation or any agreement, instrument, decree, judgment or order to which either [iDoc/VSee]
or the Company is a party or by which either [iDoc/VSee] or the Company may be bound or to which the Shares and Company Common Stock
may be subject, except for defaults or violations that would not result in a material adverse effect on [iDoc/VSee] or the Company. There
is no action, suit, proceeding or investigation pending, or currently threatened, against [iDoc/VSee] or the Company that questions the
validity of this Agreement or the rights of [iDoc/VSee] or the Company to enter into this Agreement, or to consummate the transactions
contemplated hereby.
(d) Valid
Issuance of the Shares. The Shares to be purchased by [INVESTOR] hereunder will, upon issuance pursuant to the terms hereof, be duly
and validly issued, fully paid and nonassessable and will be free from any liens or encumbrances created by either [iDoc/VSee] or the
Company (except as provided in this Agreement with respect to federal and applicable state securities laws). Based in part upon the representations
of [INVESTOR] in Section 3 of this Agreement, the Shares, when issued and delivered pursuant to this Agreement, will be issued in
compliance with federal and all applicable state securities laws. Subject in part to the truth and accuracy of [INVESTOR]’s representations
set forth in Section 3 of this Agreement, the offer, sale and issuance of the Shares as contemplated by this Agreement are exempt from
the registration requirements of the Securities Act of 1933, as amended, and neither [iDoc/VSee], the Company nor any authorized agent
acting on their behalf has taken or will take any action hereafter that would cause the loss of such exemption.
(e) Company
Common Stock. Concurrently with the consummation of the Business Combination, the Company and [INVESTOR] shall enter into a Registration
Rights Agreement, substantially in the form attached as Exhibit B to that certain Exchange Agreement, dated November 21, 2023, by and
among the Company, [iDoc/VSee], VSee Lab, Inc. and [INVESTOR] , with respect to the Shares issuable upon conversion of the Loan Amount
(the “Registration Rights Agreement”). The Company shall, following the closing of the Business Combination, register
the Shares issuable upon conversion of the Loan Amount pursuant to and in accordance with such Registration Rights Agreement. The Shares
will, upon issuance, be duly and validly issued, fully paid and nonassessable, will be free from any liens or encumbrances created by
either [iDoc/VSee] or the Company and will be freely tradeable without restriction under federal and state securities laws upon effective
registration thereof.
(f) Capitalization.
The capitalization of each of [iDoc/VSee] and the Company as of immediately prior to the closing of the Business Combination is as set
forth on the Disclosure Schedule, which Disclosure Schedule also includes the number of shares of Common Stock owned beneficially, and
of record, by Affiliates of the Company as of the date hereof. Neither [iDoc/VSee] nor the Company have issued any Capital Stock or Stock
Equivalent since its most recently filed periodic report under the Exchange Act except (i) as set forth on the Disclosure Schedule, (ii)
for the issuance of shares of [iDoc/VSee] Common Stock or the Company Common Stock to employees pursuant to the [iDoc/VSee]’s or
the Company’s employee stock purchase plans, (iii) pursuant to the conversion and/or exercise of Stock Equivalents outstanding as
of the date of the most recently filed periodic report under the Exchange Act as set forth on the Disclosure Schedule or (iv) as set forth
in the SEC Reports. Except as set forth in the SEC Reports, no Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in, or triggered by, the transactions contemplated by the Transaction Documents. The issuance of the
Shares will not obligate [iDoc/VSee] to issue shares of Common Stock or any other securities to any Person (other than to [INVESTOR])
and will not result in a right of any holder of securities issued by any of [iDoc/VSee] or Subsidiaries to adjust the exercise, conversion,
exchange or reset price under any Stock Equivalent. All of the outstanding shares of Capital Stock of [iDoc/VSee] and the Company are
duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all securities Regulations, and no
such outstanding share was issued in violation of any preemptive right or similar or other right to subscribe for or purchase securities
or any other existing Contractual Obligation. No further approval or authorization of any stockholder, [iDoc/VSee]’s Board of Directors
or the Company’s Board of Directors, and no other Permit or Consent, is required for the issuance of the Shares. Except as disclosed
in the SEC Reports, there are no stockholders’ agreements, voting agreements or other similar Contractual Obligations with respect
to [iDoc/VSee]’s Capital Stock, the Company’s Capital Stock or Stock Equivalents to which [iDoc/VSee] or the Company is a
party or, to the knowledge of [iDoc/VSee] or the Company, between or among any of [iDoc/VSee]’s or the Company’s stockholders
or other equity investors.
(g) Material
Adverse Effects; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof or on the Disclosure
Schedule: (i) there has been no event that has had, or could reasonably be expected to result in, a Material Adverse Effect, (ii) no Company
Party has incurred any Indebtedness or other liability (contingent or otherwise) other than (A) trade payables and accrued expenses incurred
in the ordinary course of business consistent with past practice and (B) liabilities not required by GAAP to be reflected in the Company’s
financial statements and not required to be disclosed in filings made with the Commission, (iii) no Company Party has altered its fiscal
year or accounting methods; (iv) no Company Party has declared or made any Restricted Payment or entered in any Contractual Obligation
to do so, (v) no Company Party has issued any Capital Stock to any officer, director or other Affiliate, and (vi) there has been no event,
liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect
to any Company Party, their Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would
be required to be disclosed by any Company Party under applicable securities Regulations at the time this representation is made or deemed
made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.
(h) Litigation.
Except as set forth in the SEC Reports or Disclosure Schedules, there is no Proceeding against any Company Party of any Subsidiary of
any Company Party or any current or former officer or director of any Company Party or any Subsidiary of any Company Party in its capacity
as such which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the
Shares, (ii) involves the Commission or otherwise involves violations of securities Regulations or (iii) could, assuming an unfavorable
result, have or reasonably be expected to result in a Material Adverse Effect, and none of the Company Parties, their Subsidiaries, or
any director or officer of any of them, is or has been the subject of any Proceeding involving a claim of violation of or liability under
securities Regulations or a claim of breach of fiduciary duty. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.
(i) Labor
Relations. There is no (i) no unfair labor practice at any Company Party and there is no unfair labor practice complaint pending against
any Company Party or any Subsidiary of any Company Party or, to their knowledge of any Company Party, threatened against any of them before
the National Labor Relations Board and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement
that is so pending against any Company Party or any Subsidiary of any Company Party or to their knowledge threatened against any of them,
(ii) no strike, work stoppage or other labor dispute in existence or to their knowledge threatened involving any Company Party or any
Subsidiary of any Company Party, and (iii) no union representation question existing with respect to the employees of any Company Party
or any Subsidiary of any Company Party, as the case may be, and no union organization activity that is taking place, except (with respect
to any matter specified in clause (i), (ii) or (iii) above, either individually or in the aggregate) such as could not reasonably likely
to have a Material Adverse Effect. None of the Company Parties’ or their respective Subsidiaries’ employees is a member of
a union that relates to such employee’s relationship with such Company Party or such Subsidiary, and none of the Company Parties
nor any of their respective Subsidiaries is a party to a collective bargaining agreement. To the knowledge of each Company Party, the
continued service to the applicable Company Party of the executive officers of such Company Party and its Subsidiaries is not, and is
not expected to be, in violation of any material term of any Contractual Obligation in favor of any third party, and does not subject
any Company Party or any Subsidiary of any Company Party to any Loss with respect to any of the foregoing matters.
(j) Compliance.
No Company Party and no Subsidiary thereof, except as set forth in the SEC Reports, on the Disclosure Schedule or as could not have or
reasonably be expected to result in a Material Adverse Effect: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by any Company Party or any Subsidiary under),
nor has any Company Party or any Subsidiary thereof received notice of a claim that it is in default under or that it is in violation
of, any Contractual Obligation (whether or not such default or violation has been waived); (ii) is in violation of any judgment, decree
or order of any Governmental Authority; (iii) is or has been in violation of any Regulation, and to the knowledge of each Company Party,
no Person has made or threatened to make any claim that such a violation exists (including relating to taxes, environmental protection,
occupational health and safety, product quality and safety, employment or labor matters) or (iv) has incurred, or could reasonably be
expected to incur Losses relating to compliance with Regulations (including clean-up costs under environmental Regulations), nor have
any such Losses been threatened.
(k) Permits.
Each Company Party and its Subsidiaries possess all Permits, each issued by the appropriate Governmental Authority, that are necessary
to conduct their respective businesses as described in the SEC Reports and which failure to possess could reasonably be expected to result
in a Material Adverse Effect and no Company Party nor any Subsidiary thereof has received any notice of proceedings relating to the revocation
or modification of any such Permit.
(l) Title
to Assets. Each Company Party and their Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good title in fee simple to all personal property owned or purported to be owned by any of them that is material to the business of
any Company Party or any Subsidiary of any Company Party, in each case free and clear of all Liens except as set forth in the SEC Reports
or on the Disclosure Schedule and except for (i) Liens that do not materially affect the value of any such property and do not materially
interfere with the use made and proposed to be made of such property by the Company Parties and their Subsidiaries and (ii) Liens for
the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the
payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by any Company Party
or any Subsidiary of the Company Parties (and any personal property if such lease is material to the business of any Company Party or
any Subsidiary of any Company Party) are held by them under valid, subsisting and enforceable leases with which the Company Parties and
their Subsidiaries party thereto are in compliance.
(m) Intellectual
Property. Except where the failure to do so would not have a Material Adverse Effect, each Company Party and each Subsidiary of the
Company Parties have, or have rights to use, all Intellectual Property Rights they purport to have or have rights to use, which, in the
aggregate for all such Company Party and such Subsidiary, constitute all Intellectual Property Rights necessary or required for use in
connection with the businesses of the Company Parties and their Subsidiary as presently conducted. No Company Party and no Subsidiary
of any Company Party has received a notice (written or otherwise) that any of the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, and, to
the knowledge of each Company Party and its Subsidiaries, no event has occurred that permits, or would permit after notice or passage
of time or both, the revocation, suspension or termination of such rights. No Company Party and no Subsidiary of any Company Party has
received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim, nor
has such a claim been threatened or could reasonably be expected to be made, and no Company Party and no Subsidiary of any Company Party
otherwise has any knowledge that any slogan or other advertising device, product, process, method, substance or other Intellectual Property
or goods or services bearing or using any Intellectual Property Right presently contemplated to be sold by or employed by Intellectual
Property Right of any Company Party or any Subsidiary of any Company Party violate or infringe upon the rights of any Person, except as
could not reasonably be expected to have a Material Adverse Effect. To the knowledge of each Company Party and its Subsidiaries, all such
Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property
Rights. Each Company Party and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value
of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. No Company Party and no Subsidiary of any Company Party has any Intellectual Property Right registered,
or subject to pending applications, in the United States Patent and Trademark Office or any similar office or agency in the United States,
any State thereof, any political subdivision thereof or in any other country, other than those set forth on the Disclosure Schedule, or
has granted any licenses with respect thereto other than as set forth on the Disclosure Schedule. The Disclosure Schedule also sets forth
all Contractual Obligations or other arrangements of any Company Party or any Subsidiary of any Company Party as in effect on the date
hereof pursuant to which such Company Party or such Subsidiary has a license or other right to use any Intellectual Property owned by
another Person and the dates of the expiration of such Contractual Obligations or other arrangements (collectively, together with such
Contractual Obligations or other arrangements as may be entered into by any Company Party or any Subsidiary of any Company Party after
the date hereof, the “License Agreements”). All material License Agreements and related rights are in full force and
effect, no default or event of default exists with respect thereto in respect of the obligations of licensor or with respect to any royalty
or other payment obligations of any Company Party or any Subsidiary of any Company Party or any obligation of any Company Party or any
Subsidiary of any Company Party with respect to manufacturing standards, quality control or specifications and each such Company Party
or such Subsidiary is in compliance with the terms thereof in all material respects and no owner, licensor or other party thereto has
sent any notice of termination or its intention to terminate such license or rights.
4.0 Representations and Warranties of [INVESTOR]
[INVESTOR] hereby represents
and warrants to each of [iDoc/VSee] and the Company as follows:
4.1 Authorization. When executed and delivered by [INVESTOR], this Agreement will constitute the valid and legally binding obligation
of [INVESTOR], enforceable in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
or other laws of general application relating to or affecting the enforcement of creditors’ rights.
4.2 Purchase Entirely for Own Account. [INVESTOR] is acquiring the Shares hereunder for its own account for investment purposes
only and not with a view to, or for resale in connection with, any “distribution” of all or any portion thereof within the
meaning of the 1933 Act.
4.3 Disclosure of Information. [INVESTOR] believes that it has received all the information it considers necessary or appropriate
for deciding whether to purchase Shares hereunder. [INVESTOR] further represents that it has had an opportunity to ask questions and receive
answers from [iDoc/VSee] regarding its business and prospects.
4.4 Experience. [INVESTOR] is experienced in evaluating and investing in companies such as [iDoc/VSee]. [INVESTOR] understands
that the investment to be made in connection with the acquisition of Shares hereunder is speculative and involves significant risk. [INVESTOR]
has no need for liquidity in this investment, has the ability to bear the economic risk of this investment, and can afford a complete
loss of the purchase price. [INVESTOR] is an “accredited investor” as that term is defined within Regulation D promulgated
under the 1933 Act.
4.5 Restricted Securities. [INVESTOR] understands that the Shares being purchased hereunder are characterized as “restricted
securities” under the federal securities laws inasmuch as they are being acquired from [iDoc/VSee] in a transaction not involving
a public offering.
3.6 Legend. [INVESTOR]
understands that the Shares have been issued pursuant to an exemption from registration or qualification under the 1933 Act and applicable
state securities laws, and except as set forth below, the Shares shall bear any legend as required by the “blue sky” laws
of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of
such stock certificates):
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
(I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B)
AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY the Company), IN A FORM REASONABLY ACCEPTABLE TO the Company, THAT REGISTRATION IS
NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
5.0 Miscellaneous Provisions.
5.1 Further Assurances. Each of the Parties agrees to cooperate fully with the other parties and to execute such further instruments,
documents and agreements and to give such further written assurances, as may be reasonably requested by any other party to better evidence
and reflect the transactions described herein and contemplated hereby, and to carry into effect the intents and purposes of this Agreement.
5.2 Notices. All notices, consents or demands of any kind which any party to this Agreement may be required or may desire to
serve on any other party hereto in connection with this Agreement shall be in writing and shall be delivered by personal service or overnight
courier, by telex or facsimile transfer, or by registered or certified mail, return receipt requested, deposited in the United States
mail with postage thereon fully prepaid, addressed: (a) if to [iDoc/VSee], at its address set forth on the signature page hereof;
(b) if to the Company, at its address set forth on the signature page hereof; or (c) if to [INVESTOR], at [INVESTOR]’s
address as set forth on the signature page below. Service of any such notice or demand so made by mail shall be deemed complete on the
date of actual delivery as shown by the addressee’s registry or certification receipt or at the expiration of the fourth (4th)
business day after the date of mailing, whichever is earlier in time. Any party hereto may from time to time by notice in writing served
upon the others as aforesaid, designate a different mailing address or a different person to which such notices or demands are thereafter
to be addressed or delivered.
5.3 Severability. The provisions of this Agreement are severable. The invalidity, in whole or in part, of any provision of this
Agreement shall not affect the validity or enforceability of any other of its provisions. If one or more provisions hereof shall be so
declared invalid or unenforceable, the remaining provisions shall remain in full force and effect and shall be construed in the broadest
possible manner to effectuate the purposes hereof. The parties further agree to replace such void or unenforceable provisions of this
Agreement with valid and enforceable provisions which will achieve, to the extent possible, the economic, business and other purposes
of the void or unenforceable provisions.
5.4 Counterparts. This Agreement may be executed in separate counterparts or by facsimile, each of which shall be deemed an
original, and when executed, separately or together, shall constitute a single original instrument, effective in the same manner as if
the parties hereto had executed one and the same instrument.
5.5 Waiver.
No waiver shall be effective unless in a writing signed by the person charged with making such waiver. Any waiver of any term, provision
or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall not be deemed to be, or be construed
as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition
of this Agreement, unless it so provides by its terms.
5.6 Entire
Agreement. This Agreement is intended by the parties hereto to be the final expression of their agreement and constitutes and embodies
their entire agreement and understanding with regard to its subject matter and is a complete and exclusive statement of the terms and
conditions thereof, and shall supersede, merge and void any and all prior correspondence, conversations, negotiations, agreements or
understandings relating to such subject matter.
5.7 Choice of Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without
regard to its conflict of laws rules or provisions.
5.8 Binding on Successors and Assigns. This Agreement and all of its terms, conditions and covenants are intended to be fully
effective and binding, to the extent permitted by law, on the executors, administrators, successors and permitted assigns of the parties
hereto.
5.9 Survival. The respective representations and warranties given by the parties shall survive such Closing without regard to
any investigation made by any party. All statements as to factual matters contained in any certificates, exhibits or other instruments
delivered by or on behalf of any party pursuant to the terms hereto or in connection with the transactions contemplated hereby shall be
deemed, for all purposes, to constitute representations and warranties by such party under the terms of this Agreement given as of the
date of such certificate or instrument.
5.10 Finder’s
Fees. Each party represents that it is not and will not be obligated for any finder’s fee or commission in connection with
this transaction.
5.11 Amendment. This Agreement shall be amended only upon the written consent of each of the Parties. Any party hereto may, as
to itself, by a writing signed by an authorized representative of such party: (a) extend the time for the performance of any of the
obligations of another party; (b) waive any inaccuracies in representations and warranties made by another party contained in this
Agreement or in any documents delivered pursuant hereto; (c) waive compliance by another party with any of the covenants contained
in this Agreement or the performance of any obligations of such other party; or (d) waive the fulfillment of any condition that is
precedent to the performance by such party of any of its obligations under this Agreement.
5.12 Expenses.
Each of the Parties shall bear their own expenses incurred with respect to this Agreement and the transactions contemplated hereby.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties
hereto have executed this Agreement with the intent and agreement that the same shall be effective as of the day and year first above
written.
|
[iDoc Virtual Telehealth Solutions, Inc./ VSee Lab, Inc.] |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
|
|
|
Digital Health Acquisition Corp. |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
|
|
|
[INVESTOR] |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
Exhibit 10.2
AMENDED AND RESTATED
SECURITIES PURCHASE AGREEMENT
This AMENDED AND RESTATED
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 13, 2024, is by and among iDoc Virtual Telehealth
Solutions, Inc., a Texas corporation (‘iDoc”), Digital Health Acquisition Corp, a Delaware corporation (the “Company”),
and Tidewater Ventures, LLC (“Tidewater”, together with iDoc and the Company the “Parties”). For
purposes of this Agreement, references to the “Company” shall also include, after the closing of the Business Combination
(as defined below), the resulting publicly listed company pursuant to the transactions contemplated by the Third Amended and Restated
Business Combination Agreement, dated November 21, 2023 (as it may be further amended or supplemented from time to time, the “Business
Combination Agreement”), by and between the Company, DHAC Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary
of the Company (“Merger Sub I”), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary of the
Company (“Merger Sub II”), VSee Lab, Inc. a Delaware corporation (“VSee”), and iDoc pursuant to
which, upon the terms and subject to the conditions contained therein, Merger Sub I will merge with and into VSee, with VSee surviving
the merger as a wholly owned subsidiary of the Company, and Merger Sub II will merge with and into iDoc, with iDoc surviving the merger
as a wholly owned subsidiary of the Company (collectively, the “Mergers”). In connection with the Business Combination,
at the effective time of the Mergers the Company will change its corporate name to VSee Health, Inc. The Mergers and the other transactions
described in the Business Combination Agreement are collectively referred to herein as the “Business Combination”.
RECITALS
A. The Parties are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by
Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b) of Regulation D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act.
B. iDoc previously delivered to Tidewater a promissory note (the “Note”) further to which the aggregate amount
of $585,000 is due and payable (the “Loan Amount”).
C. In
connection with the Business Combination, the Note will be assumed by the Company. Immediately following the closing of the Business
Combination, Tidewater wishes to convert the entire Loan Amount into shares of the Company’s common stock (the “Company
Common Stock”) at $2.00 per share (the “Shares”), and the Company wishes to sell Tidewater such Shares at
said closing, upon the terms and conditions stated in this Agreement. In connection with the Business Combination, the Company will register
shares of its common stock (the “Company Common Stock”) issuable upon exchange of the Shares for an identical number of shares
of Company Common Stock.
D. Following the closing of the Business Combination, the Company will register the Shares issuable upon conversion of the Loan Amount.”
NOW THEREFORE, THE PARTIES
AGREE AS FOLLOWS:
1.0
Basic Terms of Purchase and Sale.
1.1 Purchase
and Sale of Shares.
(a) Subject
to the terms and conditions of this Agreement, immediately following the closing of the Business Combination, Tidewater agrees to purchase
from the Company, and the Company agrees to sell and issue to Tidewater, 292,500 Shares at $2.00 per Share. Each of the Parties acknowledges
that the Loan Amount shall be the only amount that will be payable in full satisfaction of the purchase price for the Shares.
(b) As
soon as practicable after the date of issuance of the Shares, the Company shall deliver to Tidewater a certificate or book entry statement
representing 292,500 Shares against delivery to each of the Company and the Company by Tidewater of evidence of the cancellation of all
amounts owing by the Company to Tidewater under the Note.
2.0 Representations
and Warranties of iDoc and the Company
2.1 Representations and Warranties of iDoc and the Company. Each of iDoc and the Company, jointly and severally, hereby represents
and warrants to Tidewater as follows:
(a) Incorporation. Each of iDoc and the Company is a corporation duly organized, validly existing and in good standing under
the laws of the State of its incorporation and each has all requisite corporate power and authority to carry on its business as now conducted
and as proposed to be conducted.
(b) Authorization.
All corporate action on the part of each of iDoc and the Company, its officers, directors and shareholders necessary for the authorization,
execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and therein, and for
the authorization, issuance and delivery of the Securities, has been or shall be taken prior to the Closing, and this Agreement, when
executed and delivered, shall constitute the legal, valid and binding obligation of each of iDoc and the Company, enforceable against
each of them in accordance with their respective terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
or other laws of general application relating to or affecting the enforcement of creditors’ rights. iDoc has all requisite legal
and corporate power to enter into this Agreement, to sell the Shares hereunder, and to carry out and perform its obligations hereunder.
(c) Valid
Issuance of the Shares. The Shares to be purchased by Tidewater hereunder will, upon issuance pursuant to the terms hereof, be duly
and validly issued, fully paid and nonassessable and will be free from any liens or encumbrances created by either iDoc of the Company
(except as provided in this Agreement with respect to federal and applicable state securities laws). Based in part upon the representations
of Tidewater in Section 3 of this Agreement, the Shares, when issued and delivered pursuant to this Agreement, will be issued in
compliance with federal and all applicable state securities laws. Subject in part to the truth and accuracy of Tidewater’s representations
set forth in Section 3 of this Agreement, the offer, sale and issuance of the Shares as contemplated by this Agreement are exempt from
the registration requirements of the Securities Act of 1933, as amended, and neither iDoc, the Company nor any authorized agent acting
on their behalf has taken or will take any action hereafter that would cause the loss of such exemption.
(d) Company Common Stock. Following the closing of the Business Combination, the Company will take all necessary action to register
the Shares issuable upon conversion of the Note. The Shares issuable upon conversion of the Note will, upon issuance, be duly and validly
issued, fully paid and nonassessable.
3.0 Representations and Warranties of Tidewater
Tidewater hereby represents
and warrants to the Company as follows:
3.1 Authorization.
When executed and delivered by Tidewater, this Agreement will constitute the valid and legally binding obligation of Tidewater, enforceable
in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws of general
application relating to or affecting the enforcement of creditors’ rights.
3.2 Purchase Entirely for Own Account. Tidewater is acquiring the Shares hereunder for its own account for investment purposes
only and not with a view to, or for resale in connection with, any “distribution” of all or any portion thereof within the
meaning of the 1933 Act.
3.3 Disclosure
of Information. Tidewater believes that it has received all the information it considers necessary or appropriate for deciding whether
to purchase Shares hereunder. Tidewater further represents that it has had an opportunity to ask questions and receive answers from the
Company regarding its business and prospects.
3.4 Experience. Tidewater is experienced in evaluating and investing in companies such as the Company. Tidewater understands
that the investment to be made in connection with the acquisition of Shares hereunder is speculative and involves significant risk. Tidewater
has no need for liquidity in this investment, has the ability to bear the economic risk of this investment, and can afford a complete
loss of the purchase price. Tidewater is an “accredited investor” as that term is defined within Regulation D promulgated
under the 1933 Act.
3.5 Restricted
Securities. Tidewater understands that the Shares being purchased hereunder are characterized as “restricted securities”
under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering..
3.6 Legend. Tidewater
understands that the Shares have been issued pursuant to an exemption from registration or qualification under the 1933 Act and applicable
state securities laws, and except as set forth below, the Shares shall bear any legend as required by the “blue sky” laws
of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of
such stock certificates):
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
(I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B)
AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY the Company), IN A FORM REASONABLY ACCEPTABLE TO the Company, THAT REGISTRATION IS
NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
4.0
Miscellaneous Provisions.
4.1 Further
Assurances. Each of the Parties agrees to cooperate fully with the other parties and to execute such further instruments, documents
and agreements and to give such further written assurances, as may be reasonably requested by any other party to better evidence and
reflect the transactions described herein and contemplated hereby, and to carry into effect the intents and purposes of this Agreement.
4.2 Notices.
All notices, consents or demands of any kind which any party to this Agreement may be required or may desire to serve on any other party
hereto in connection with this Agreement shall be in writing and shall be delivered by personal service or overnight courier, by telex
or facsimile transfer, or by registered or certified mail, return receipt requested, deposited in the United States mail with postage
thereon fully prepaid, addressed: (a) if to iDoc, at its address set forth on the signature page hereof; (b) if to the Company,
at its address set forth on the signature page hereof; or (c) if to Tidewater, at Tidewater’s address as set forth on the
signature page below. Service of any such notice or demand so made by mail shall be deemed complete on the date of actual delivery as
shown by the addressee’s registry or certification receipt or at the expiration of the fourth (4th) business day after
the date of mailing, whichever is earlier in time. Any party hereto may from time to time by notice in writing served upon the others
as aforesaid, designate a different mailing address or a different person to which such notices or demands are thereafter to be addressed
or delivered.
4.3 Severability. The provisions of this Agreement are severable. The invalidity, in whole or in part, of any provision of this
Agreement shall not affect the validity or enforceability of any other of its provisions. If one or more provisions hereof shall be so
declared invalid or unenforceable, the remaining provisions shall remain in full force and effect and shall be construed in the broadest
possible manner to effectuate the purposes hereof. The parties further agree to replace such void or unenforceable provisions of this
Agreement with valid and enforceable provisions which will achieve, to the extent possible, the economic, business and other purposes
of the void or unenforceable provisions.
4.4 Counterparts. This Agreement may be executed in separate counterparts or by facsimile, each of which shall be deemed an
original, and when executed, separately or together, shall constitute a single original instrument, effective in the same manner as if
the parties hereto had executed one and the same instrument.
4.5 Waiver.
No waiver shall be effective unless in a writing signed by the person charged with making such waiver. Any waiver of any term, provision
or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall not be deemed to be, or be construed
as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition
of this Agreement, unless it so provides by its terms.
4.6 Entire Agreement. This Agreement is intended by the parties hereto to be the final expression of their agreement and constitutes
and embodies their entire agreement and understanding with regard to its subject matter and is a complete and exclusive statement of the
terms and conditions thereof, and shall supersede, merge and void any and all prior correspondence, conversations, negotiations, agreements
or understandings relating to such subject matter.
4.7 Choice
of Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to
its conflict of laws rules or provisions.
4.8 Binding
on Successors and Assigns. This Agreement and all of its terms, conditions and covenants are intended to be fully effective and binding,
to the extent permitted by law, on the executors, administrators, successors and permitted assigns of the parties hereto.
4.9 Survival. The respective representations and warranties as contained herein shall survive such Closing Date without regard
to any investigation made by any party.
4.10 Finder’s
Fees. Each party represents that it is not and will not be obligated for any finder’s fee or commission in connection with
this transaction.
4.11 Amendment.
This Agreement shall be amended only upon the written consent of each of the Parties. Any party hereto may, as to itself, by a writing
signed by an authorized representative of such party: (a) extend the time for the performance of any of the obligations of another
party; (b) waive any inaccuracies in representations and warranties made by another party contained in this Agreement or in any
documents delivered pursuant hereto; (c) waive compliance by another party with any of the covenants contained in this Agreement
or the performance of any obligations of such other party; or (d) waive the fulfillment of any condition that is precedent to the
performance by such party of any of its obligations under this Agreement.
4.12
Expenses. Each of the Parties shall bear their own expenses incurred with respect to this Agreement and the transactions
contemplated hereby.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties
hereto have executed this Agreement with the intent and agreement that the same shall be effective as of the day and year first above
written.
|
iDoc Virtual Telehealth Solutions, Inc. |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
|
|
|
Digital Health Acquisition Corp. |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
|
|
|
Tidewater Ventures, LLC |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Address: |
v3.24.0.1
Cover
|
Feb. 13, 2024 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Feb. 13, 2024
|
Entity File Number |
001-41015
|
Entity Registrant Name |
Digital Health Acquisition Corp.
|
Entity Central Index Key |
0001864531
|
Entity Tax Identification Number |
86-2970927
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
980 N Federal Hwy #304
|
Entity Address, City or Town |
Boca
Raton
|
Entity Address, State or Province |
FL
|
Entity Address, Postal Zip Code |
33432
|
City Area Code |
561
|
Local Phone Number |
672-7068
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Units, each consisting of one share of Common Stock and one Redeemable Warrant [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Units, each consisting of one share of Common Stock and one Redeemable Warrant
|
Trading Symbol |
DHACU
|
Security Exchange Name |
NASDAQ
|
Common Stock [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Common Stock, par value $0.0001 per share
|
Trading Symbol |
DHAC
|
Security Exchange Name |
NASDAQ
|
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
|
Trading Symbol |
DHACW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=dhacu_UnitsEachConsistingOfOneShareOfCommonStockAndOneRedeemableWarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=dhacu_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOfDollar11.50Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Digital Health Acquisition (NASDAQ:DHACU)
Historical Stock Chart
From Jul 2024 to Aug 2024
Digital Health Acquisition (NASDAQ:DHACU)
Historical Stock Chart
From Aug 2023 to Aug 2024